SIGNIFY
Study assessInG the morbidity–mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
- Stadium
- klaar
- Middel
- ivabradine
- Populatie
- ASCVD
- Fase
- III
- First Patient In
- 15 mei 2009
- Last Patient In
- 1 mei 2012
- Last Patient Last Visit
- -
Studiedirecteur
